Unlock instant, AI-driven research and patent intelligence for your innovation.

Uses of Growth Hormone Fragments

A growth hormone, human growth hormone technology, applied in the field of growth hormone peptide fragments, can solve problems such as limited clinical application

Active Publication Date: 2019-06-18
METABOLIC PHARMA LTD
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Therefore, the clinical application of hGH is currently limited

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Uses of Growth Hormone Fragments
  • Uses of Growth Hormone Fragments
  • Uses of Growth Hormone Fragments

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0169] Example 1: Determination of the effect of AOD on cartilage repair by assessing tissue formation:

[0170] method

[0171] Cell Culture and Therapy

[0172] Chondrocytes were aseptically isolated from articular cartilage obtained from the calf metacarpal-carpal joint and seeded on type II collagen-coated membrane inserts (Millipore TM )(1.5×10 6 cells / 12mm diameter membrane). Chondrocytes were grown in Ham's F-12 supplemented with 5% fetal bovine serum (FBS) under standard culture conditions. After 5 days, serum increased to 20%. Chondrocytes were then grown for 2 weeks in the presence and absence of AOD9604 (SEQ ID NO: 1 ) (10 or 100 μg / ml) (total culture time 3 weeks). Add fresh AOD each time the medium is changed.

[0173] organizational assessment

[0174] The tissue was harvested and digested with papain (Sigma, 40 g / ml) for 48 h at 65°C. DNA content was determined using Hoechst 33258 dye binding assay (Polysciences) and fluorometry (excitation 365 nm, emiss...

Embodiment 2

[0181] Example 2: Effect of AOD on natural cartilage

[0182] method

[0183] Cartilage explants were removed from the calf metacarpal-carpal joint and cultured in Ham's F-12 supplemented with 20% fetal bovine serum (FBS) in the presence or absence of AOD9604 (SEQ ID NO: 1) (AOD9604 was 10 or 100g / ml) for 1 week or (AOD9604 is 100 or 500g / ml) for 2 weeks.

[0184] organizational assessment

[0185] The tissue was harvested, and the water content and dry weight were measured. Tissues were then digested with papain (Sigma, 40 μg / ml) at 65°C for 48h. DNA content was determined using Hoechst 33258 dye binding assay (Polysciences) and fluorometry (excitation 365 nm, emission 458 nm). Proteoglycan content was determined by measuring the amount of sulfated glycosaminoglycans using a dimethylmethylene blue dye binding assay and spectrophotometry (525 nm). Collagen content was determined by measuring the hydroxyproline content of an aliquot of the hydrolyzed papain digest in 6NHCl a...

Embodiment 3

[0195] Example 3: Effect of peptide AOD9604 on the differentiation of myoblasts into myocytes in vitro

[0196] method

[0197] Cell Culture and Therapy

[0198] Under standard cell culture conditions, C2C12 was grown in monolayer culture in DMEM (high glucose) supplemented with 10% fetal bovine serum. Cells were passaged at 60-70% confluence. By making cells (3000 cells / cm 2 ) were grown for 3 days in the absence or presence of AOD9604 (10 and 100 μg / ml) to determine the effect of AOD9604 (SEQ ID NO: 1 ) on cell proliferation. DNA content was then quantified. Cells were digested by papain and DNA content was determined using Hoechst 33258 dye binding assay (Polysciences) and fluorometry (excitation 365 nm, emission 458 nm).

[0199] Cellular Differentiation Assessment

[0200] C2C12 (2×10 3 cells / cm 2 ) were grown in DMEM and 10% FBS. Differentiation was induced by replacing the growth medium with a differentiation medium consisting of DMEM supplemented with 2% hor...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
Login to View More

Abstract

The present invention provides methods for the treatment of conditions in which the administration of growth hormone is beneficial, for the treatment of osteoarthritis, for increasing chondrocyte, proteoglycan or collagen production or quality or for repairing or promoting cartilage tissue formation or Repairing, for promoting or improving muscle, ligament or tendon quality, repair, formation or function, or for treating inflammatory, traumatic or genetic disorders of muscle or connective tissue, comprising administering to a subject an effective amount of a peptide, the The peptide includes the carboxy-terminal sequence from growth hormone and does not include the IGF-1 domain of growth hormone. Also provided is a method of treating a condition involving insufficient functional chondrocytes or insufficient functional cartilage tissue comprising administering to a subject in need thereof a peptide comprising the carboxy-terminal sequence from growth hormone and excluding the IGF responsible for ‑1 domain of growth hormone produced.

Description

technical field [0001] The present invention relates to the use of peptide fragments of growth hormone to treat conditions treatable by growth hormone without the side effects associated with the use of growth hormone. Background technique [0002] All references, including any patents or patent applications, cited in this specification are hereby incorporated by reference to enable a full understanding of the present invention. However, these references are not to be construed as constituting an admission that any of these documents form part of the common general knowledge in the art, in Australia or any other country. The discussion of the references states what their authors assert, and the applicants reserve the right to challenge the accuracy and pertinence of the cited documents. [0003] Somatotropin or growth hormone (GH) is a potent anabolic hormone produced by the pituitary gland in children and young adults in amounts of 0.5 mg to 0.8 mg per day. Its production...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K38/18A61P19/02A61P19/04A61P21/06
CPCA61K38/27A61P1/14A61P17/02A61P19/02A61P19/04A61P21/00A61P21/04A61P21/06A61P25/00A61P29/00A61P3/04A61P31/18A61P43/00A61P5/06A61P9/00A61K38/18A61K35/28
Inventor D·肯利
Owner METABOLIC PHARMA LTD